TSX:EMA - Toronto Stock Exchange - CA2908761018 - Common Stock - Currency: CAD
Mentions: EMA.PR.L.CA EMA.PR.J.CA EMA.PR.CA EMA.PR.F.CA
Mentions: EMA.PR.L.CA EMA.PR.J.CA EMA.PR.CA EMA.PR.F.CA
Mentions: EMA.PR.L.CA EMA.PR.J.CA EMA.PR.CA EMA.PR.F.CA
Mentions: EMA.PR.L.CA EMA.PR.J.CA EMA.PR.CA EMA.PR.F.CA
Mentions: EMA.PR.L.CA EMA.PR.J.CA EMA.PR.CA EMA.PR.F.CA
Mentions: EMA.PR.L.CA EMA.PR.J.CA EMA.PR.CA EMA.PR.F.CA
Mentions: EMA.PR.L.CA EMA.PR.J.CA EMA.PR.CA EMA.PR.F.CA
Mentions: EMA.PR.L.CA EMA.PR.J.CA EMA.PR.CA EMA.PR.F.CA
Mentions: EMA.PR.L.CA EMA.PR.J.CA EMA.PR.CA EMA.PR.F.CA
Mentions: EMA.PR.L.CA EMA.PR.J.CA EMA.PR.CA EMA.PR.F.CA
Mentions: EMA.PR.L.CA EMA.PR.J.CA EMA.PR.CA EMA.PR.F.CA
Mentions: EMA.PR.CA EMA.PR.F.CA EMA.PR.J.CA EMA.PR.L.CA
Mentions: EMA.PR.CA EMA.PR.F.CA EMA.PR.J.CA EMA.PR.L.CA
Forecasted to become a hurricane, Tropical Storm Helene is expected to hit Florida on Thursday, causing potential flooding and affecting multiple companies
Mentions: EMA.PR.CA EMA.PR.F.CA EMA.PR.J.CA EMA.PR.L.CA
Mentions: EMA.PR.CA EMA.PR.F.CA EMA.PR.J.CA EMA.PR.L.CA
Mentions: EMA.PR.CA EMA.PR.F.CA EMA.PR.J.CA EMA.PR.L.CA
Mentions: EMA.PR.CA EMA.PR.F.CA EMA.PR.J.CA EMA.PR.L.CA
Mentions: EMA.PR.CA EMA.PR.F.CA EMA.PR.J.CA EMA.PR.L.CA
Mentions: EMA.PR.CA EMA.PR.F.CA EMA.PR.J.CA EMA.PR.L.CA
Emera Incorporated (TSX:EMA:CA) declares CAD 0.69/share quarterly dividend, in line with previous.Forward yield 3.9%Payable Feb. 15; for shareholders of record Feb. 1; ex-div Jan.
Shares of Canadian utility Emera Inc. fell the most in more than two years after Nova Scotia’s government proposed rules to cap electricity price hikes.
Mentions: TSLA
Mentions: EMA.PR.CA EMA.PR.F.CA EMA.PR.J.CA EMA.PR.L.CA
Mentions: EMA.PR.CA EMA.PR.F.CA EMA.PR.J.CA EMA.PR.L.CA
Mentions: EMA.PR.CA EMA.PR.F.CA EMA.PR.J.CA
European health ministers will discuss the future of AstraZeneca Plc’s Covid-19 vaccine after a growing number of countries suspended its use to examine side effects, potentially throwing the region’s already slow inoculation campaign further off track.
Europe’s slow vaccination push has sunk further into disarray after some of the biggest countries suspended AstraZeneca Plc’s shot to explore its effects, compounding a crisis of confidence around a promising path out of the pandemic.
Europe’s slow vaccination push has sunk further into disarray after some of the biggest countries suspended AstraZeneca Plc’s shot to explore its effects, compounding a crisis of confidence around a promising path out of the pandemic.
The European Union’s medicines regulator is set to recommend Johnson & Johnson’s coronavirus vaccine early next month, bolstering supplies even as governments struggle to get shots into people’s arms.
Mentions: EMA.PR.CA EMA.PR.F.CA